1 Adenis, A.; Conroy,T.; Lasser,P.; Merrouche,Y.; Monges , G.: Carcinoma of the colon; British Journal of Cancer; 2001, 84, Suppl.2, S. 65- 68

2 Aitken, R.A: Growing Edge of Measurements of Feelings; Proc. roy. Soc. Med.; 1969, 62, S. 989-996

3 Andreyev, H.J.N.: Why do Patients with Weight Loss have a Worse Outcome when Undergoing Chemotherpy for Gastrointestinal Malignancies?; l Eur J Canc; 1998, Vol. 34, No.4,S. 503-509

4 Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland: Krebs in Deutschland, Häufigkeiten und Trends; Arbeitsgemeinschaft Bevölkerungsbezogener Krebsregister in Deutschland, R.-Koch- Institut; 3. Auflage, Saarbrücken 2002

5 Ballmer, P.: Causes and Mechanisms of Hypoalbuminaemia; Clinical Nutrition; 2001, 20 (3), S.271-273

6 Banks, W. : Anorectic Effects of Circulating Cytokines: Role of the Vascular Blood-Brain Barrier; Nutrition; 2001, 17,S. 434-437

7 Baracos, V.: Hypercatabolism and Hypermetabolism in Wasting States; Current Opinion in clinical nutrition and metabolic care; 2002, 5,S. 237-239

8 Barber, M.D.; Ross, J.;Fearon, K.: Disordered Metabolic Response with Cancer and its Management; World Journal of Surgery; 2000, 24,S. 681-689

9 Baumann, H.; Gauldie, J.: The Acute Phase Response; Immunology Today; Vol.15, 1994, S. 74-80

10 Bernhard, J.; Maibach, R.; Thürlimann, B., Sessa, C.; Aapro, M.: Patients' Estimation of Overall Treatment Burden: Why Not Ask the Obvious?; Journal of Clinical Oncology; 2002, 20, S. 65- 72

11 Bernhard, J.; Sullivan, M.;Coates, A.; Rudenstam,C.: Clinical relevance of single item quality of life indicators in cancer clinical trials; British Journal of Cancer; 2001, 84 (9), S.1156-1165

12 Berthold, H.: Arzneimitteltherapie; 1. Auflage; Jena, Gustav Fischer Verlag, 1999

13 Berthoud, H.; Seeley, R.: An overview of neural pathways and networks involved in the control of food intake and selektion; Neuroscience Biobehaviour Review; 1999, 24, S. 361-387

14 Birch, L.: Developement of Food Preferences; Annual Review of Nutrition; 1999, 19, S. 41-62

15 Bley, T.; Rastall, R.: Altered Taste in Patients with Jaundice; Clinical Nutrition; 2003, 22, S. 58-59

16 Bossola,M.; Muscaritoli,M.; Bellatone,R.;Pacelli,F.; Cascino,A.; Sgadari,A.: Serum Tumor Necrosis Factor alpha Lvels in Cancer Patients are discontinuous and correlate with Weight Loss; European Journal of Clinical Investigation ; Vol.30, 2000, S. 1107-1112

17 Boyle, P.; Langman, J.: ABC of colorectal cancer; British Journal of Medicine; 2000, 321, S. 805-808

18 Brenna,F.B.: Uncomplicated starvation versus cancer cachexia; Cancer Research; 37, 1977, S. 7-12

19 Bruning, P.; Egger, R.; Gooskens, A.; Odink, J, Kistemaker, C.: Dietary Intake, Nutritional Status and Well-being of Cancer Patients: a Prospective Study; European Journal of Cancer and Clinical Oncology, 1985, 21, S. 1449-1459

20 Cahlin, Ch.; Körner, A.; Axelson, H.; Wang, W.; Lundholm, K.: Experimental Cancer Cachexia: The Role of Host-derived Cytokines Interleukin IL-6, Il-12, Interferon gamma and Tumor Necrosis Factor alpha Evaluated in Gene KNockout, Tumor-bearing Mice on C57 BI Background and Eicosanoid-dependent Cachexia, Cancer Research, Vol.60, 2000, S. 5488-5493

21 Coates, A.; Fischer Dillenbeck, C.; McNeil, D.: On the Receiving End- II. Linear Analogue Selfassessment (LASA) in Evaluation of Aspects of the Quality of Life of Cancer Patients Receiving Therapy; Eur J Cancer Clin Oncol, 1983, 19., Nov., S. 1633-1637

22 Copeland, K.: Acute growth hormone effects on amino acid and lipid metabolism; J Clin Endocrinol Metab; 1994, 78, S.1040-1047

23 Crown,A.; Cottle, K.; Lightman, S.; Falk, S.: What is the role of the insulin-like growth factor system in the pathophysiology of cancer cachexia, and how is it regulated?; Clinical Endocrinology; 2002, 56, S.723-733

24 deBraud, F.; Cascinu, S.; Gatta, G.: Cancer of pancreas; Clinical Reviews in Oncology/Hematology; 2004, 50, S.147-155

25 DeWys, WD.: Prognostic effect of weight loss prior to chemotherapy in cancer patients; American Journal of Medicine; 1980, 69, S.491-497

26 Dietrich, Ch.: Therapie des Hepatozellulären Karzinoms; Dt. Aerztebl; 2003, 12, S. A772- 782

27 Drewnowski, A.: Taste Preferences and Food Intake; Annual Review of Nutrition; 1997, 17, S. 237-253

28 Drewnowski, A.; Ahlstrom Henderson, S.; Barrat-Fornell, A.: Genetic taste markers and food preferences; Drug Metabolism and Dispostion; 2001, 29, S. 535-538

29 Drewnowski, A.; Hann, C.: Food preferences and reported frequencies of food consumption as predictors of current diet in young women ; American Journal of Clinical Nutrition, 1999, 70, S. 28-36

30 Dworzak,F.; Ferrari, P.; Gavazzi, C.; Maiorana, C.: Effects of Cachexia Due to Cancer on Whole Body and Skeletal Muscle Protein Turn Over; Cancer; Vol.82, 1998, S.42-48

31 Edington,J.: Prevalence of Malnutrition on admission to four hospitals in England; Clinical Nutrition; 2000, 19 (3), S.191- 195

32 Ehab, H.; Alexiou,M.; Morgan, J.; Penagaricano,J.; Fan, C.:Intensive Chemoradiotherapy as a Primary Treatment for Organ Preservation in Patients with Advenced Cancer of the Head and Neck; Arch Otolaryngol Head Neck Surg; 2004, 130, S. 861-868

33 Eickhoff, A.; Jakobs, R.; Riemann, J.: Ösophagus- und Magenkarzinom; Der Internist; 2004, 45, S. 756-768

34 Fanelli, F.: Cancer anorexia: a model for the understanding and treatment of secondary anorexia ; International Jounal of Cardiology; 2002, 85, S.67- 72

35 Fearon, K.; Barber,M.; Falconer, J.; McMillian, D.; Ross, J.; Preston,T.: Pancreatic Cancer as a Model: Inflammatory Mediators, Acute Phase Response and Cancer Cachexia; World Journal of Surgery, 1999, 23, S.584-588

36 Fearon, K.; Moses, A.: Cancer cachexia; International Journal of Cardiology, 2002, 85, S.73- 81

37 Forbes, St.; Bui, St.; Robinson,B.; Hochgeschwender, U.; Brennan,M.: Integrated control of appetit and fat metabolism by the leptin-proopiomelanocortin pathway PNAS; Physiology; 2001, 98 (7), S. 4233-4237

38 Fordy,C.; Glover, C.; Henderson, D.C.; Summerbell, C.: Contribution of Diet, Tumor Volume and Patient-Related Factors to Weight Loss in Patients with Colorectal Liver Metastases; British Journal of Surgery; 1998, 5, S. 639-644

39 Forro, M.; Cieslar, S.; Ecker, G.; Walzak, D.: Total body water and ECFV measured using bioelectrical impedance analysis and indicator dilution in horses; Journal of Applied Physiology; 2000, 89/2, S. 663-671

40 Foster, K.: Whole Body Impedance- what does it measure?; Am J CLin Nutr; 1996, 64 , S. 388S- 396S

41 Franch-Arcas, G.: The meaning of hypoalbuminaemia in clinical practice; Clinical Nutrition; 2001, 20 (3), S. 265-269

42 Frisancho, A.: Triceps skin fold and upper arm muscle size norms for assessment of nutritional status; American Journal of Clinical Nutrition; 1974, 27, S.1052-1058

43 Frisancho, A.: New norms of upper limb fat and muscle areas for assessment of nutritional status; American Journal of Clinical Nutrition; 1981, 34, S. 2540-2545

44 Fuchs, E.: Diagnostik und Therapie gastrointestinaler Tumoren; Onkologie Eschweiler; Nora Verlag GmbH, Stolberg, 2002

45 Galvan, O.; Sprinzl, G.; Hackl, J.; Gunkel, A.: Stellenwert eines Ernährungsscores bei Patienten mit fortgeschrittenen Karzinomen im Kopf-Hals-Bereich; HNO; 2000, 48, S. 928-936

46 Gelin, J.: The metabolic response to cancer; Proc Nutr Soc; 1992, 51, S. 279-284

47 Giovanni, M.;Elias, D.; Raoul, JL.; Rougier, P.: Hepatocellular Carcinoma; British Journal of Cancer; 2001, 84 Suppl. 2, S. 74- 77

48 Gough, I.; Furnival, C.; Schilder, L.: Assessment of the Quality of Life of Patients with Advanced Cancer; Eur J Cancer Clin Oncol; 1983, 19 (Aug), S.1161-1165

49 Hahn J.-M.: Innere Medizin; Stuttgart, Georg Thieme Verlag; 1997, 3. Auflage, "

50 Hall, J.C.: Altered taste thresholds in gastrointestinal cancer; Clinical Oncology; 1980, 6, S. 137-142

51 Hanna, E.; Alexiou, M.; Morgan, J.;Badley, J.: Intensive Chemoradiotherapy as a Primary Treatment for Organ Preservation in Patients with Advanced Cancer of the Head and Neck; Arch Otolaryngol Head Neck Surg; 2004 , 130 , S. 861-867

52 Harrison, G.: Harrisons Innere Medizin; M. Dietel, J. Dudenhausen, N. Suttorp; 15. Auflage, Berlin, ABW Wissenschaftsverlag, 2001

53 Heber, D.; Tchekmedyian, N.: Pathophysiology of cancer: hormonal and metabolic abnormalities; Oncology ; 49 Suppl2, 1992, S. 28-31

54 Heymsfield, S.; McManus, C.; Stevens, V.; Smith, J.: Muscle mass:reliable indicator of protein-energy malnutrition severity and outcome ; American Journal of Clinical Nutrition; 35, 1982, S. 1192-1199

55 Heymsfield, S.; ZiMian, W.: Human Body Composition: Advances in Models and Methods; Annual Reviews Nutrition;17, 1997, S. 527-558

56 Heymsfield, St.: Techniques used in the measurement of body composition:an overview with emphasis on bioelectrical impedance analysis; American Journal of Clinical Nutrition; 64 Suppl, 1996, S. 478S-484S

57 Heymsfield, St.: Anthropometric measurement of muscle mass: revised equations for calculating bone-free arm muscle area; American Journal of Clinical Nutrition; 1982, 36, S. 680-690

58 Hirsch, J.: The interactions of nutrition and behavior; American Journal of Nutrition; 1982, 35, S. 1200-1201

59 Holm, E: Substrate Balances across Colonic Carcinoma in Humans; Cancer Research; 55, 1995, S. 1373-1378

60 Hulgji, A., Geisbers, A.; Poelhuis, E.; Hart, A.: Alterations in taste appreciation in cancer patients during treatment; Cancer Nursing; 1986, 9, S. 38-42

61 Inui, A.: Cancer anorexia-cachexia syndrome- are neuropeptides the key?; Cancer Research; 1999, 59, S. 4493- 4501

62 Ipsen, B.; Kondrup, J.: Weight maintenance in cancer patients during chemo- or radiotherapy; Journal of Clinical Nutrition; 2003, 22, S.64 -66

63 Isenring, E.; Capra, S.; Bauer, J.: Nutrition intervention is beneficial in oncology outpatients receiving radiotherapy to the gastrointestinal or head and neck area; British Journal of Cancer; 2004, 91, S. 447-452

64 Ito, H.; Miki, C.: Profile of circulating levels of lnterleukin-1 Receptor Antagonist and Interleukin-6 in colorectal cancer patients ; Scandinavian Journal of Gastroenterology; 1999, 11, S.1139-1140

65 Johnson, F.; Grace, M.: Alterations in taste sensation: a case presentation of a patient with endstage pancreatic cancer; Cancer Nursing; 2001, 24 , S.149-155

66 Katschinski, M.: Regulation von Appetit und Sättigung; Aktuelle Ernährungsmedizin; 2002, 27, S. 375-380

67 Khan, S.; Tisdale, M.: Catabolism of Adipose Tissue by a Tumor-Produced Lipid-Mobilising Factor; International Journal of Cancer; 1999, 80, S. 444-447

68 Koch, J.: The role of body composition measurements in wasting syndromes; Seminars in Oncology; 25 Suppl.6, 1998, S. 800 -810

69 Koolman, J. , Röhm, K.: Taschenatlas der Biochemie; Stuttgart, Georg Thieme Verlag, 3. Auflage, "

70 Kotler, DP.: Magnitude of body cell mass depletion and the timing of death from wasting in aids; Am J Clin Nutr; 1989, 50, S. 444-447

71 Kreibich Fischer, R.: Psychological Aspects of Malnutrition; Recent Results in Cancer Research;121, 1991, S. 296-300

72 Langhans, W.: Zentrale Regulation der Nahrungsaufnahme; Aktuelle Ernährungsmedizin; 2002, 27, S. 381-388

73 Langhans, W.; Hrupka, B.: Interleukins and tumor necrosis factor as inhibitors of food intake; Neuropeptides; 1999, 35/5, S. 415-424

74 Lazarus,D.; Destree, A.; Mazzola, L.; McCornack,T.; Dick, L.; BiXu, J.; Pierce, J .: A New Model of Cancer Cachexia: Contribution of the Ubiquitin- Proteasome Pathway; American Journal of Physiology- Endocrinology and Metabolism; Vol.27, 1999, S. E332-E341

75 Llovera, M.; Garcia-Martinez, C.; López-Soriano, J.; Carbó, N.; Agell, N.: Role of TNF receptor 1 in protein turnover during cancer cachexia using gene knock out mice; Molecular and Cellular Endocrinology, 1998, 142, S. 183-189

76 Llovet, J.; Bruix, J.: Early diagnosis and treatment of hepatocellular carcinoma; Clinical Gastroentology; 2000, 6, S. 991-1008

77 Lukaski, H.: Biological indexes considered in the derivation of the bioelectrical impedance analysis; Am J Clin Nutr; 1996, 64, S. 397S-404S

78 Mackiewicz, A.: Acute Phase Response; Molecular Biology, Biochemistry and Clinical Applications; CRC Press; 1993, 1, S. 686 -691

79 Mantovani, G.; Maccio, A.; Mura, L.; Mudu, M.; Madeduddu, C.: Serum Levels of Leptin and Proinflammatory Cytokines in Patients with advanced-stage Cancer at different Sites; Journal of Molecular Medicine; 2000 , 78 (10),S. 554-561

80 Martin, F.; Santolaria, F.; Batista, N.; Milena, A.: Cytokins Levels (IL-6 and IFN-gamma), Acute Phase Response and Nutritional Status as Prognostic Factors in Lung Cancer; Cytokine; Vol.11, 1999, S. 80-86

81 Mattes, R.: Clinical Implications of Learned Food Aversions in Patients with Cancer Treated with Chemotherapy or Radiation; Therapy Cancer; 1999, 21, S. 192-200

82 National Institutes of Health Technology: Bioelectrical impedance analysis in body composition measurement: National Institutes of Health Technology assessment conference statement; American Journal of Clinical Nutrition; 1996, 64(Suppl), S. 524S- 532S

83 Nelson, K.: The Cancer-Anorexia-Cachexia Syndrome; Seminars in Oncology; 27, 2000, S. 64-6 9

84 Neumeiser, B.: Klinikleitfaden Labordiagnostik; 2. Auflage, München und Jena; Urban und Fischer Verlag, 2000

85 Ng, K.; Woo, J.; Kwan, M.; Lo, R.; Chan, A.: Effect of Age and Disease on Taste Perception; Journal of Pain and Symptom Management; 2004, 28.,S. 28-34

86 Nielsen, S.; Athanasios, T.; Vickers, Z.: Influence of food odors on food aversions and preferences in patients with cancer; American Journal of Clinical Nutrition; 1980, 33, S. 2253-2261

87 Ollenschläger, G.; Schrappe- Bächer, B.; Steffen, M.; Bürger, B.; Allolio, B.: Erhebung des Ernährungszustandes in der klinischen Routinediagnostik: Cholinesterase- Aktivität als Ernährungsindikator ; Klinische Wochenschrift; 1989, 67, S.1101- 1107

88 Ollenschläger, G.; Thomas, W.; Konkol, K.;Diehl, V.; Roth, E.: Nutritional behaviour and quality of life during oncological polychemotherapy: Results of a prospective study on the efficacy of oral nutrition therapy in patients with acute leukaemia ; European Journal of Clinical Investigation; 1992, 22, S. 546-553

89 Ollenschläger, O.: Zur Pathogenese und Therapie der Malnutrition in der Onkologie; Zeitschrift für Ernährungswissenschaft; 1982, 21, S.124-145

90 Opera, E.: Correlation between food intake and CSF IL- 1 in anorectic tumor bearing rats; NeuroReport; 1995, 6, S. 750- 752

91 Ortner, M.: Photodynamic therapy for cholangiocarcinoma; J-Hepatobiliary-Pancreat-Surg.; 2001, 8, S. 137-139

92 Ott, M .: Early changes of body composition in human immunodeficiency virus infectd patients: Tetrapolar body impedance analysis indicates significant malnutrition; Am J Clin Nutr; 1993, 57, S. 15-19

93 Pirlich, M.; Plauth, M.; Lochs, H.: Bioelektrische Impedanzanalyse: Fehlerquellen und methodische Grenzen bei der klinischen Anwendung zur Analyse der Körperzusammensetzung ; Akt.Ernähr.-Med.; 1999, 24, S. 81-90

94 Pirlich, M.; Schütz, T.; Kemps, M.; Luhmann, N.;Plauth, M.;Lübke, H.; Lochs, H.: Prevalence of Malnutrition in Hospitalized Medical Patients: Impact of Underlying Disease; Digestive Disease; 2003, 21, S. 245-251

95 Pirlich, M.; Schwenk, A.; Müller, M.; Ockenga, J.; Schütz, T.; Selberg, O.: DGEM-Leitlinie Enterale Ernährung: Ernährungsstatus; Aktuelle Ernährungsmedizin; 2003, 28, S. S10-S25

96 Preiß, K.: Onkologie 2000; Onkologische Arbeitsgemeinschaft Saar-Pfalz-Mosel e. V.; 10. Auflage W. Zuckschwerdt Verlag, 2000, "

97 Pschyrembel: Klinisches Wörterbuch; H. Hildebrandt ; 257. Auflage , Berlin, Walter de Gruyter, 1995, "

98 Puccio,M.; Nathanson,L.: The Cancer Cachexia Syndrome; Seminars in Oncology; Vol.24, 1997,S. 277-287

99 Raben, A.; Tagliabue,A.;Astrup, A.: The reproducibility of subjective appetite scores; British Journal of Nutrition; 1995, 73, S. 517-530

100 Ravasco, P.; Grillo, I.; Marques Vidal, P.; Camilo, M.: Nutrition and Patient Outcome: a prospective randomised controlled trial in colorectal cancer patients undergoing radiotherapy; Journal of Clinical Nutrition; 2003, 22, S. S63

101 Roubenoff, R.: Standardization of nomenclature of body composition in weight loss; American Journal of Clinical Nutrition; 1997, 66, S.192-196

102 Schindler, K.;Sunder-Plassmann, G.: Protein-Energie- Malnutrition und Organdysfunktion; Aktuelle Ernährungsmedizin; 2001, 26, S. 56-61

103 Schlag,P.; Decker-Baumann,C.: Strategies and needs for nutritional support in cancer surgery; Recent Results in Cancer Research; 121, 1991, S. 45-52

104 Schwenk, A.; Beisenherz, A.; Römer, K.;Kremer, G.; Elia, M.: Phase angle from bioelectrical impedance analysis remains an independent predictive marker in HIV-infected patients in the era of highly active antiretroviral treatment; American Journal of Clinical Nutrition; 2000, 72/2, S. 496-501

105 Seitz,J.; Sarradet, A.; Francois, E.; Jacob,J.; Rougier, P.; Roussel, A.: Carcinoma of the Oesophagus; British Journal of Cancer; 2001, 84 Suppl.2, S. 61- 64

106 Selberg, O.: Ursachen und Charakteristika der Tumorkachexie-Perspektiven einer ernährungsmedizinischen Behandlung; Ernährungsumschau; 47, 2000, S. 298-303

107 Seppelt, B.; Zunft, H.: Sensitivität und Präferenz zum Süßgeschmack unter langfristig verändertem Kohlenhydratverzehr; Ernährungsumschau, 2000, 1, S. 385-399

108 Sharma, R.; Anker, S.: Cytokines, apoptosis and cachexia: the potential for TNF antagonism; International Journal of Cardiology; 2002, 85, S.161-171

109 Smith, B.K.: Anti TNF-alpha antibodies normalised body temperature and enhanced food intake in tumor bearing rats; Am J Physiol; 1993, 265, S. R615 -622

110 Spangenberg, H.; Thimme, R.; v.Weizsäcker,F.; Blum, E.: Hepatozelluläres Carzinom; Der Internist; 2004, 45, S. 777-785

111 Strassmann, G.: Evidence for the involvement of IL-6 in experimental cancer cachexia; J Clin Invest;1992,89, S. 1681 -1689

112 Tisdale, M.: Protein Loss in Cancer Cachexia; Science; Vol.289, 2000, S. 2293-2295

113 Tisdale, M.: Cancer Anorexia and Cachexia; Nutrition; 2001, 17, S.438-442

114 Tisdale, M.: Wasting in Cancer; Journal of Nutrition; 1999, 1, S. 243S-246S

115 Trant, A.: Is taste related to anorexia in cancer patients?; American Journal of Clinical Nutrition; 1982, 36 (7), S. 45-58

116 Volk, H.D.: Skript Einführung in theoretische Grundlagen der Immunologie; Berlin 1998; S.17

117 Wang,W.; Iresjö,B.; Karlsson,L.; Svanberg,E.: Provision of rhIGF-I/ IGFBP-3 complex attenuated development of cancer cachexia in an experimental tumor model; Clinical Nutrition, 2000, 2, S.127-132

118 Wickham, R.; Rehwaldt, M.; Kefer, C.: Taste changes experienced by patients receiving chemotherapy; Oncology Nurse Forum; 1999, 26, S. 697-706

119 Wils, J.; O'Dwyer, P.; Labianca, R.: Treatment of colorectal cancer at the turn of the century: European and US perspectives ; Annals of Oncology; 2001, 12, S. 13-20

120 Wolff/ Weihrauch: Internistische Therapie 2000/ 2001; Urban & Fischer Verlag; 13. Auflage, München/ Jena, Urban & Fischer Verlag, 2000

121 Yackinous, C.; Guinard, J.: Relation between PROP (6-n-propylthiouracil) taster status, taste anatomy and dietary intake measures for young man and women; Appetite; 2002, 38, S. 201-209

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am: